Similar articles

• Progesterone.

  Maggio L, Rouse DJ. Maggio L, et al. Clin Obstet Gynecol. 2014 Sep;57(3):547-56. doi: 10.1097/GRF.0000000000000039. Clin Obstet Gynecol. 2014. PMID: 24936913 Review.
• The safety of progestogen in the prevention of preterm birth: meta-analysis of neonatal mortality.

  Ahn KH, Bae NY, Hong SC, Lee JS, Lee EH, Jee HJ, Cho GJ, Oh MJ, Kim HJ. Ahn KH, et al. J Perinat Med. 2017 Jan 1;45(1):11-20. doi: 10.1515/jpm-2015-0317. J Perinat Med. 2017. PMID: 27124668
• The Use of Isomolecular Progesterone in the Support of Pregnancy and Fetal Safety.

  Hilgers TW, Keefe CE, Pakiz KA. Hilgers TW, et al. Issues Law Med. 2015 Autumn;30(2):159-68. Issues Law Med. 2015. PMID: 26710374 No abstract available.
• 17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? Someone should.

  O'Brien JM. O'Brien JM. Am J Obstet Gynecol. 2011 May;204(5):e16-7; author reply e17. doi: 10.1016/j.ajog.2010.12.001. Epub 2011 Jan 28. Am J Obstet Gynecol. 2011. PMID: 21276949 No abstract available.
• Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.

  O'Brien JM, Lewis DF. O'Brien JM, et al. Am J Obstet Gynecol. 2016 Jan;214(1):45-56. doi: 10.1016/j.ajog.2015.10.934. Epub 2015 Nov 10. Am J Obstet Gynecol. 2016. PMID: 26558340 Review.